conferences

(NASDAQ:SBRA) TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #CONFERENCES--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chair and Chief Executive Officer, Michael Costa, the company’s Chief Financial Officer, Talya Nevo-Hacohen, the company’s Chief Investment Officer, Darrin Smith, the company’s Executive Vice President of Investments, and Lukas Hartwich, the company’s Executive Vice President of Finance, will host Jefferies during their So Cal Tour on September 30, 2025, at Sabra’s corpor

FALLS CHURCH, Va.--(BUSINESS WIRE)--The Product Stewardship Society announces an exceptional lineup of sponsors for PSX 2025, the society's premier conference for product stewardship professionals. PSX sponsors will support cutting-edge educational sessions, enhanced networking opportunities, and comprehensive career development programs throughout PSX 2025, which will be held from September 16-18 in Houston, Texas. The sponsors for this year's conference are: 3E™ – platinum designation Benchma

YOKOHAMA, Japan--(BUSINESS WIRE)-- #BusinessEvents--The IADR General Session & Exhibition, the world’s largest dental research meeting, will be held in Yokohama, returning to Japan after 28 years.

Global research and advisory firm Info-Tech Research Group has announced that registration is now open for the Canadian edition of its renowned Info-Tech LIVE 2025 conference. Taking place November 25–26, 2025, at the Fairmont The Queen Elizabeth in Montreal, the two-day event will unite...

Birchtech Invited to Attend Upcoming Investor Conferences

(NASDAQ:CRIS) LEXINGTON, Mass., Sept. 2, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that James Dentzer, President and Chief Executive Officer of Curis,...

(NYSE:DBRG) BOCA RATON, Fla.--(BUSINESS WIRE)--DigitalBridge Group, Inc. (“DigitalBridge” or the “Company”) (NYSE: DBRG), a leading global alternative asset manager dedicated to investing in digital infrastructure, today announced that senior executives from DigitalBridge will participate in the following upcoming investor and industry events: September 3: Barclays 39th Annual Energy-Power Conference – New York, NY Marc Ganzi, Chief Executive Officer at DigitalBridge, will deliver a fireside chat on Wednes

(NASDAQ:CJMB) SPRING BRANCH, Texas, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that management will participate in the following September 2025 investment conferences.

(NASDAQ:ALXO) SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced that ALX Oncology leadership will participate in both the Cantor Global Healthcare Conference 2025 and H.C. Wainwright 27th Annual Global Investment Conference in New York.

(NASDAQ:IOVA) SAN CARLOS, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that senior leadership plans to present at the following conferences:

Alumis management will participate in several healthcare conference upcoming in September

(NASDAQ:ZNTL) SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types, today announced that members of the management team will participate in the following upcoming investor conferences:

(NASDAQ:ATAI) NEW YORK and AMSTERDAM, Aug. 28, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes, today announced that its management is scheduled to participate in upcoming September investor conferences.

(NASDAQ:KROS) LEXINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (“TGF-ß”) family of proteins, today announced that Keros’ President and Chief Executive Officer Jasbir S. Seehra, Ph.D., will present at the following healthcare conferences:

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in the following upcoming investor conferences:

CHARLESTOWN, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences:

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in September 2025: Cantor Global Healthcare Conference Presentation: Thursday, September 4, 2025, 10:20 a.m. ET Location: New York, NY Morgan Stanley 23rd Annual Global Healthcare Conference Fireside Chat: Tuesday, September 9, 2025, 2:35 p.m. ET Location: New York, NY Live webcasts wi

WEST PALM BEACH, Fla., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Dycom Industries, Inc. (NYSE: DY) announced today that the Company will participate in the following upcoming institutional investor conferences:

SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company management team will participate in the following investor conferences in September:

JERUSALEM, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will present and meet investors in the following five investor conferences in September 2025.